Abstract
Thyrotoxicosis occurs more frequently during the post-partum period than at other times in women of childbearing age. Graves’ disease and post-partum thyroiditis are two major causes of thyrotoxicosis in this period. The major task lies in differentiation of these two diseases in the post-partum period; since throtoxicosis caused by post-partum thyroiditis usually does not require treatment. The radioiodine uptake is elevated or normal in Graves’ disease and low in post-partum thyroiditis, and TSH-receptor antibodies are positive in Graves’ and negative in post-partum thyroiditis. Post-partum thyrotoxicosis due to Graves’ disease may be treated with radioiodine but it requires radiation safety measurements for infant and is contraindicated if the mother is breast-feeding. Antithyroid drugs are the mainstay of the treatment of post-partum thyrotoxicosis. Recent investigations conclude that neither propylthiouracil nor methimazole cause any alterations in thyroid function and physical and mental development of infants breast-fed by lactating thyrotoxic mothers, and both can be safely administered in moderately high doses during lactation. (J. Endocrinol. Invest. 29: 244–247, 2006)
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amino N, Tanizawa O, Mori H, et al. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves’ disease. J Clin Endocrinol Metab 1982, 55: 108–12.
Lazarus JH, Lueate M. Prevention and treatment of postpartum Graves’ disease Bailliere’s Clin Endocrinol Metab 1997, 11: 549–60.
de los Santos ET, Starich GH, Mazzaferri EL. Sensitivity, specificity and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. Arch Intern Med 1989, 149: 526–32.
Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003, 348: 2646–55.
Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab Clin North Am 1998, 27: 169–85.
Arem R, Munipalli B. Ipodate therapy in patients with severed destruction-induced thyrotoxicosis. Arch Intern Med 1996, 156: 1752–7.
Azizi F, Khoshniat M, Bahrainian M, Hedayati M. Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 2000, 85: 3233–8.
Williams RH, Kay GA, Jandorf BJ. Thoracic, its absorption, distribution, and excretion. J Clin Invest 1994, 23: 613–27.
Low LC, Lang J, Alexander WD. Excretion of carbimazole and propylthiouracil in breast milk. Lancet 1979, 10: 1011.
Kampmann JP, Johansen K, Hansen JM, Hewleg J. Propylthiouracil in human milk. Revision of a dogma. Lancet 1980, 1: 736–7.
McDougall IR, Bayer MF. Should a women taking propylthiouracil breast-feed? Clin Nucl Med 1986, 11: 249–50.
Cooper DS. Antithyroid drugs: to breast-feed or not to breast-feed. Am J Obstet Gynecol 1987, 157: 234–5.
Mamotani N, Tamashita R, Toshimoto M, Noh J, Ishikawa N, Ito K. Recovery from foetal hypothyroidism: evidence for the safety of breast-feeding while taking propythouracil. Clin Endocrinol (Oxf) 1989, 31: 591–5.
Momotani N, Yamashita R, Makino F, et al. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil. Clin Endocrinol (Oxf) 2000, 53: 177–81.
Johansen K, Andersen AK, Kampman JP, Hansen JM, Mortensen HB. Excretion of methimazole in human milk. Eur J Clin Pharmacol 1982, 23: 339–41.
Cooper DS, Bode HH, Nath B, Saxe V, Maloof F, Ridgway EC. Methimazole pharmacology in many studies using a newly developed radioimmunoassay for methimazole. J Clin Endocrinol Metab 1984, 58: 473–9.
Lamberg B.A, Ikonen E, Osterlund K, et al. Antithyroid treatment of maternal hyperthyroidism during lactation. Clin Endocrinol (Oxf) 1984, 21: 81–7.
Azizi F. Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants. J Pediatr 1996, 128: 855–7.
Azizi F, Hedayati M. Thyroid function in breast-fed infants whose mothers take high doses of methimazole. J Endocrinol Invest 2002, 25: 493–6.
Azizi F, Bahrainian M, Khamseh M, Khoshniat M. Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. J Pediatr Endocrinol Metab 2003, 16: 1239–43.
Azizi F. Thyroid function in breast-fed infants is not affected by methimazole-induced maternal hypothyroidism: Results of a retrospective study. J Endocrinol Invest 2003, 26: 301–4.
Zaton A, Martinez A, DeGandaris JM. The binding of thioureleyne compounds to human serum albumin. Biochem Pharmacol 1988; 37: 3127–3131.
Abe Y, Sato H, Sakai H, Odyama N. Antithyroid treatment of maternal hyperthyroidism during lactation. Proc 11th International Thyroid Congress, Toronto, Canada. Thyroid 1995, 5: S108.
Mountford PJ, Coakley AJ. A review of the secretion of radioactivity in human breast milk: data, quantitative analysis, and recommendations. Nucl Med Commun 1989, 10: 15–27.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Azizi, F. Treatment of post-partum thyrotoxicosis. J Endocrinol Invest 29, 244–247 (2006). https://doi.org/10.1007/BF03345547
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345547